Diet and gut microbiome in fatty liver and its associated liver cancer

被引:24
|
作者
Pan, Yasi
Zhang, Xiang
机构
[1] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, CUHK Shenzhen Res Inst, State Key Lab Digest Dis,Inst Digest Dis,Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, CUHK Shenzhen Res Inst, Dept Med & Therapeut,Shatin, Hong Kong, Peoples R China
基金
中国国家自然科学基金;
关键词
diet; gut microbiome; HCC; NASH; NONALCOHOLIC STEATOHEPATITIS; INTESTINAL MICROBIOTA; FRUCTOSE CONSUMPTION; INSULIN-RESISTANCE; ADVANCED FIBROSIS; SATURATED FAT; HONG-KONG; DISEASE; OBESITY; ACIDS;
D O I
10.1111/jgh.15713
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Non-alcoholic fatty liver disease (NAFLD) is the major cause of chronic liver disease worldwide as a consequence of a sedentary lifestyle and overnutrition. NAFLD could progress to non-alcoholic steatohepatitis (NASH), which may further develop to cirrhosis and hepatocellular carcinoma (HCC). The gut microbiome is one of the central regulators in host metabolism. Diet could change human gut microbiome rapidly and reproducibly and modulate several metabolic pathways. Both diet and gut microbiome dysbiosis are associated with NAFLD and its related HCC (NAFLD-HCC). Dietary cholesterol, fiber, fat, or carbohydrate could change the microbiome composition to contribute to the development of NASH and NAFLD-HCC. Hence, identification of elements of the gut-liver axis that are primarily damaged in NASH and NAFLD-HCC offers new possibility for therapeutic intervention. In this review, the roles of gut microbiome and microbial metabolites in the development and progression of NAFLD and NAFLD-HCC are first discussed. The impacts of different diet compositions including cholesterol, fiber, fat, and sugar on the gut microbiome that leads to predisposition to NASH and NAFLD-HCC are also explored. We summarized the article by discussing potential therapeutic implication of diet and microbiome modulation in fatty liver and liver cancer.
引用
收藏
页码:7 / 14
页数:8
相关论文
共 50 条
  • [41] The gut microbiome and intestinal failure-associated liver disease
    Lu Jiang
    Juan Xu
    Si-Yang Cheng
    Ying Wang
    Wei Cai
    Hepatobiliary & Pancreatic Diseases International, 2023, 22 (05) : 452 - 457
  • [42] The gut microbiome and intestinal failure-associated liver disease
    Jiang, Lu
    Xu, Juan
    Cheng, Si-Yang
    Wang, Ying
    Cai, Wei
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2023, 22 (05) : 452 - 457
  • [43] Gut microbiome in liver pathophysiology and cholestatic liver disease
    Yan, Shengmin
    Yin, Xiao-Ming
    LIVER RESEARCH, 2021, 5 (03) : 151 - 163
  • [44] Western diet-induced mouse model of non-alcoholic fatty liver disease associated with metabolic outcomes: Features of gut microbiome-liver-adipose tissue axis
    Romualdo, Guilherme R.
    Valente, Leticia Cardoso
    Sprocatti, Ana Carolina
    Bacil, Gabriel Prata
    de Souza, Isadora Penedo
    Rodrigues, Josias
    Rodrigues, Maria Aparecida Marchesan
    Vinken, Mathieu
    Cogliati, Bruno
    Barbisan, Luis Fernando
    NUTRITION, 2022, 103-104
  • [45] Gut-Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome
    Pezzino, Salvatore
    Sofia, Maria
    Faletra, Gloria
    Mazzone, Chiara
    Litrico, Giorgia
    La Greca, Gaetano
    Latteri, Saverio
    BIOLOGY-BASEL, 2022, 11 (11):
  • [46] Impact of Clonorchis sinensis on gut microbiome in liver cancer patients
    Seth, Abhinav
    Chan, Carlos
    Fang, Zhong-Liao
    Jackson, Brooks
    Jiang, Zhi-Hua
    Lu, Xu Wei
    Liang, Ming Yong
    Tang, Wen Qian
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S184 - S185
  • [47] Animal Models of Non-alcoholic Fatty Liver Diseases and Its Associated Liver Cancer
    Lau, Jennie Ka Ching
    Zhang, Xiang
    Yu, Jun
    OBESITY, FATTY LIVER AND LIVER CANCER, 2018, 1061 : 139 - 147
  • [48] Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer
    Tuo Deng
    Jialiang Li
    Bangjie He
    Bo Chen
    Fangting Liu
    Ziyan Chen
    Jiuyi Zheng
    Zhehao Shi
    Tan Zhang
    Liming Deng
    Haitao Yu
    Jinhuan Yang
    Lijun Wu
    Yunfeng Shan
    Zhengping Yu
    Xiaolei Chen
    Yi Wang
    Gang Chen
    Hepatology International, 2022, 16 : 99 - 111
  • [49] Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer
    Deng, Tuo
    Li, Jialiang
    He, Bangjie
    Chen, Bo
    Liu, Fangting
    Chen, Ziyan
    Zheng, Jiuyi
    Shi, Zhehao
    Zhang, Tan
    Deng, Liming
    Yu, Haitao
    Yang, Jinhuan
    Wu, Lijun
    Shan, Yunfeng
    Yu, Zhengping
    Chen, Xiaolei
    Wang, Yi
    Chen, Gang
    HEPATOLOGY INTERNATIONAL, 2022, 16 (01) : 99 - 111
  • [50] Gut microbiome and metabolic response in non-alcoholic fatty liver disease
    Abuwani, Asmita Madatali
    Dash, Shweta Priyadarshini
    Ganesan, Raja
    Renu, Kaviyarasi
    Vellingiri, Balachandar
    Kandasamy, Sabariswaran
    Rajan, Sundara C. R.
    Gopalakrishnan, Abilash Valsala
    CLINICA CHIMICA ACTA, 2021, 523 : 304 - 314